Author: Huang, Qingrui; Zeng, Jiawei; Yan, Jinghua
Title: COVID-19 mRNA vaccines Cord-id: kz1wmqad Document date: 2021_3_15
ID: kz1wmqad
Snippet: The ongoing COVID-19 pandemic and its unprecedented global societal and economic disruptive impact highlights the urgent need for safe and effective vaccines. Taking substantial advantages of versality and rapid development, two mRNA vaccines against COVID-19 have completed late-stage clinical assessment at an unprecedented speed and reported positive results. In this review, we outline key notes in mRNA vaccine development, discuss recently published data on COVID-19 mRNA vaccine candidates, fo
Document: The ongoing COVID-19 pandemic and its unprecedented global societal and economic disruptive impact highlights the urgent need for safe and effective vaccines. Taking substantial advantages of versality and rapid development, two mRNA vaccines against COVID-19 have completed late-stage clinical assessment at an unprecedented speed and reported positive results. In this review, we outline key notes in mRNA vaccine development, discuss recently published data on COVID-19 mRNA vaccine candidates, focusing on those in clinical trials and analyze future potential challenges.
Search related documents:
Co phrase search for related documents- long term safety and low incidence: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date